Segment disclosures

Company overview

PTC THERAPEUTICS, INC.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 19 retained observations 13 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Operating Segments · Life Science Segment

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=ptct:LifeScienceSegmentMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30357807000 USD2026-10-29 · 20:31:05.000ZOpen filing evidence
2026-01-01 – 2026-09-30990877000 USD2026-10-29 · 20:31:05.000ZOpen filing evidence
2026-04-01 – 2026-06-30360519000 USD20260730Open filing evidence
2026-01-01 – 2026-06-30633070000 USD20260730Open filing evidence
2026-01-01 – 2026-03-31272551000 USD20260507Open filing evidence
2025-01-01 – 2025-12-311730655000 USD20260219Open filing evidence
2025-07-01 – 2025-09-30211007000 USD2026-10-29 · 20:31:05.000ZOpen filing evidence
2025-01-01 – 2025-09-301565978000 USD2026-10-29 · 20:31:05.000ZOpen filing evidence
2025-04-01 – 2025-06-30178875000 USD20260730Open filing evidence
2025-01-01 – 2025-06-301354971000 USD20260730Open filing evidence
2025-01-01 – 2025-03-311176096000 USD20260507Open filing evidence
2024-01-01 – 2024-12-31806780000 USD20260219Open filing evidence
2024-07-01 – 2024-09-30196786000 USD20251104Open filing evidence
2024-01-01 – 2024-09-30593608000 USD20251104Open filing evidence
2024-04-01 – 2024-06-30186704000 USD20250807Open filing evidence
2024-01-01 – 2024-06-30396822000 USD20250807Open filing evidence
2024-01-01 – 2024-03-31210118000 USD20250506Open filing evidence
2023-01-01 – 2023-12-31937822000 USD20260219Open filing evidence
2022-01-01 – 2022-12-31698801000 USD20250227Open filing evidence